Cereno Scientific appoints Eva Jagenheim as Chief Financial Officer (CFO)
Cereno Scientific (Nasdaq First North: CRNO B), a company developing innovative treatments for common and rare cardiovascular disease, today announced that Eva Jagenheim is appointed Chief Financial Officer (CFO). Jagenheim has broad experience in finance and the Swedish biotech sector. She will join the company on August 28, 2023.“We are excited to welcome Eva to the Cereno team. She brings a wealth of experience and valuable financial expertise from previous roles in public biotech companies,” said Sten R. Sörensen, CEO of Cereno. Eva Jagenheim, born 1966, has an M.Sc. in Business and